AI assistant
Sending…
BIO-TECHNE Corp — Director's Dealing 2025
Nov 3, 2025
30718_dirs_2025-11-03_15c71edc-c06b-4ecf-8e01-aef7f5cae46a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2025-10-30
Reporting Person: Klimovsky Judith V. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-10-30 | Common Stock | A | 1640 | — | Acquired | 3782 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-10-30 | Stock Option (Right to Buy) | $60.96 | A | 3777 | Acquired | 2035-10-30 | Common Stock (3777) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $73.46 | 2034-05-01 | Common Stock (1610) | 1610 | Direct |
| Stock Option (Right to Buy) | $68.37 | 2034-10-24 | Common Stock (3511) | 3511 | Direct |
Footnotes
F1: The option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders.
More from BIO-TECHNE Corp
Regulatory Filings
2026
Jun 1
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 19
Board/Management Information
2026
Feb 11
Director's Dealing
2026
Feb 5
Interim / Quarterly Report
2026
Feb 4